Bolt Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,141 | $1,275 | $5,274 | $2,089 |
Gross Profit | 1,141 | -14,158 | 4,816 | 1,592 |
EBITDA | -16,003 | -18,575 | -16,634 | -19,299 |
EBIT | -16,443 | -19,032 | -17,092 | -19,796 |
Net Income | -15,176 | -21,195 | -10,811 | -17,903 |
Net Change In Cash | 1,141 | 1,275 | 5,274 | 2,089 |
Free Cash Flow | -14,007 | -16,142 | -16,751 | -14,271 |
Cash | 9,366 | 6,202 | 4,262 | 10,810 |
Basic Shares | 38,250 | 38,128 | 38,068 | 37,941 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,876 | $5,729 | $1,260 | $231 |
Gross Profit | 5,992 | 838 | -2,412 | -40,126 |
EBITDA | -74,342 | -88,655 | -91,595 | -48,571 |
EBIT | -76,196 | -93,546 | -95,267 | -51,075 |
Net Income | -69,197 | -85,875 | -104,394 | -72,274 |
Net Change In Cash | 7,876 | 5,729 | 1,260 | 231 |
Free Cash Flow | -69,731 | -78,457 | -59,404 | -50,570 |
Cash | 10,810 | 9,244 | 27,383 | 5,542 |
Basic Shares | 37,811 | 37,358 | 37,399 | 36,246 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.40 |
2024-06-30 | -$0.46 |
2024-03-31 | -$0.28 |
2023-12-31 | -$0.47 |
